Rezolute, Inc. Files 8-K on Shareholder Votes and Financials

Ticker: RZLT · Form: 8-K · Filed: Nov 21, 2025 · CIK: 1509261

Rezolute, Inc. 8-K Filing Summary
FieldDetail
CompanyRezolute, Inc. (RZLT)
Form Type8-K
Filed DateNov 21, 2025
Risk Levellow
Pages3
Reading Time3 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: corporate-action, financial-reporting

TL;DR

Rezolute filed an 8-K on Nov 19th covering shareholder votes & financials. Check it out.

AI Summary

Rezolute, Inc. filed an 8-K on November 21, 2025, reporting on matters submitted to a vote of security holders and financial statements/exhibits. The filing date for the report is November 19, 2025. The company, formerly known as AntriaBio, Inc., is incorporated in Nevada and headquartered in Redwood City, California.

Why It Matters

This 8-K filing provides an update on important corporate actions and financial reporting for Rezolute, Inc., which could influence investor decisions.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of corporate events and financial information, not indicating any immediate financial distress or significant operational change.

Key Players & Entities

  • Rezolute, Inc. (company) — Registrant
  • November 19, 2025 (date) — Date of earliest event reported
  • Nevada (jurisdiction) — State of Incorporation
  • Redwood City, CA (location) — Principal Executive Offices
  • AntriaBio, Inc. (company) — Former Company Name

FAQ

What specific matters were submitted to a vote of security holders by Rezolute, Inc. on November 19, 2025?

The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.

What financial statements and exhibits are included in this 8-K filing?

The filing states that Financial Statements and Exhibits are included, but the specific content is not detailed in the provided text.

When was Rezolute, Inc. incorporated, and where is its principal executive office located?

Rezolute, Inc. was incorporated in Nevada and its principal executive offices are located at 275 Shoreline Drive, Suite 500, Redwood City, CA 94065.

What was Rezolute, Inc.'s former company name?

Rezolute, Inc.'s former company name was AntriaBio, Inc.

What is the SEC file number and EIN for Rezolute, Inc.?

The SEC file number for Rezolute, Inc. is 001-39683, and its EIN is 27-3440894.

Filing Stats: 766 words · 3 min read · ~3 pages · Grade level 11.4 · Accepted 2025-11-21 16:59:48

Key Financial Figures

  • $0.001 — ch registered Common Stock, par value $0.001 per share RZLT Nasdaq Capital Market

Filing Documents

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. Rezolute, Inc. (the " Company ") held its 2026 annual meeting of stockholders on November 19, 2025. The meeting was held virtually at www.virtualshareholdermeeting.com/RZLT2025. As of the record date, September 22, 2025, there were a total of 90,811,368 shares of common stock outstanding and entitled to vote at the special meeting. At the annual meeting, 66,700,068 shares of common stock were represented in person (virtually) or by proxy; therefore, a quorum was present. The final voting results for the matters submitted to a vote of stockholders were as follows: Proposal No. 1 - Election of Directors To elect the following nominees to serve as members of the Company's board of directors: Nominee Name Votes For Votes Withheld Broker Non Votes Nevan Charles Elam 59,206,610 161,306 7,332,152 Young-Jin Kim 52,980,022 6,387,894 7,332,152 Gil Labrucherie 55,354,306 4,013,610 7,332,152 Philippe Fauchet 58,711,617 656,299 7,332,152 Nerissa Kreher, M.D. 45,487,489 13,880,427 7,332,152 Wladimir Hogenhuis, M.D. 45,753,848 13,614,068 7,332,152 Erik Harris 48,235,273 11,132,643 7,332,152 Proposal No. 2 - Ratification of Independent Registered Public Accounting Firm To ratify Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending on June 30, 2026: Votes For Votes Against Abstentions Broker Non Votes 65,206,245 937,798 556,025 - Proposal No. 3 - Say-on-Pay Proposal To approve by a non-binding advisory vote, the compensation of the Company's named executive officers, as disclosed in the Executive Compensation section of the proxy statement: Votes For Votes Against Abstentions Broker Non Votes 40,149,598 19,193,827 24,491 7,332,152 Proposal No. 4- Equity Plan Amendment Proposal To approve an amendment to the Company's 2021 Stock Incentive Plan (the " 2021 Equity Plan Amendment Proposal ") to in

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. The following Exhibits are furnished as part of this Current Report on Form 8-K. Exhibit No. Description 104 Cover Page Interactive Data File (formatted as inline XBRL)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. REZOLUTE, INC. DATE: November 21, 2025 By: /s/ Nevan Elam Nevan Elam Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.